pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Asparlas
drug
save

calaspargase pegol

Marketedupdated 3mo ago
by Servier Pharmaceuticals LLC
Approved
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying calaspargase pegol

  • phase1Venetoclax Basket Trial for High Risk Hematologic Malignanciesrecruitingn=30
  • phase1CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)recruitingn=7
  • phase2Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)recruitingn=100
  • phase3SPARK-ALL: Calaspargase Pegol in Adults With ALLterminatedn=42
  • phase3Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphomaactive not recruitingn=790
  • phase1Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Canceractive not recruitingn=15
  • phase2Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclaxactive not recruitingn=35

News(0)

no news has mentioned this drug yet

brand
Asparlas
generic
calaspargase pegol
indication
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 56m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?